Drug Shortage Report for ANGELIQ
Report ID | 73486 |
Drug Identification Number | 02268825 |
Brand name | ANGELIQ |
Common or Proper name | drospirenone and estradiol |
Company Name | BAYER INC |
Market Status | MARKETED |
Active Ingredient(s) | DROSPIRENONE ESTRADIOL |
Strength(s) | 1.0MG 1.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 28's |
ATC code | G03FA |
ATC description | PROGESTOGENS AND ESTROGENS IN COMBINATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-03-11 |
Actual start date | |
Estimated end date | 2019-04-17 |
Actual end date | 2019-03-18 |
Shortage status | Resolved |
Updated date | 2019-03-19 |
Company comments | Product is now available to market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-01-24 | English | Compare |
v2 | 2019-01-24 | French | Compare |
v3 | 2019-01-24 | French | Compare |
v4 | 2019-02-16 | English | Compare |
v5 | 2019-02-27 | English | Compare |
v6 | 2019-02-27 | French | Compare |
v7 | 2019-03-12 | English | Compare |
v8 | 2019-03-18 | English | Compare |
v9 | 2019-03-18 | French | Compare |
v10 | 2019-03-19 | English | Compare |
Showing 1 to 10 of 10